FinancialContent is the trusted provider of stock market information to the media industry.
More NewsRead More
Galectin Therapeutics' Abstract Accepted as Oral Presentation at The Liver Meeting(R), Annual Meeting of the American Association for the Study of Liver Diseases
October 01, 2014
EQUITY ALERT: Rosen Law Firm Reminds Galectin Therapeutics, Inc. Investors of Important September 29, 2014 Class Action Deadline -- GALT
September 26, 2014
Hagens Berman Reminds Galectin Investors 4 Days Remain in Lead Plaintiff Class-Action Deadline
September 25, 2014
Galectin Therapeutics Elects Gilbert S. Omenn, M.D., Ph.D., a Leading Cancer Researcher, to Its Board of Directors
September 24, 2014
Biotech Stocks Technical Data - Medivation, Galectin Therapeutics, Ironwood Pharma, Achillion Pharma, and PDL BioPharma
September 16, 2014
from PR Newswire
Galectin Therapeutics (GALT) Tops Q3 EPS by 10c
November 10, 2014
INSIGHT-After hep C cure, companies target next big liver disease market
November 09, 2014
Commit To Purchase Galectin Therapeutics At $2.50, Earn 19% Annualized Using Options
October 07, 2014
from Market News Video
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here